Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesia
- 1 September 2018
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 121 (3) , 559-566
Abstract
No abstract availableKeywords
Funding Information
- Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea (2015-552)
- University of Ulsan College of Medicine (16)
This publication has 34 references indexed in Scilit:
- Predictive performance of the modified Marsh and Schnider models for propofol in underweight patients undergoing general anaesthesia using target-controlled infusionBritish Journal of Anaesthesia, 2017
- Comparison of the clinical performance of the modified Marsh model for propofol between underweight and normal-weight patients with Crohn's diseaseKorean Journal of Anesthesiology, 2017
- A General Purpose Pharmacokinetic Model for PropofolAnesthesia & Analgesia, 2014
- Effectiveness, safety, and pharmacokinetic and pharmacodynamic characteristics of microemulsion propofol in patients undergoing elective surgery under total intravenous anaesthesiaBritish Journal of Anaesthesia, 2010
- Pharmacokinetic models for propofol—defining and illuminating the devil in the detailBritish Journal of Anaesthesia, 2009
- Evaluation of the predictive performance of four pharmacokinetic models for propofolBritish Journal of Anaesthesia, 2009
- Impact of Body Mass Index on Perioperative Outcomes in Patients Undergoing Major Intra-abdominal Cancer SurgeryAnnals of Surgical Oncology, 2008
- Socioeconomic, psychosocial, behavioural, and psychological determinants of BMI among young women: differing patterns for underweight and overweight/obesityEuropean Journal of Public Health, 2005
- Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patientsInternational Journal of Cancer, 2001
- Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of RemifentanilAnesthesiology, 1997